Beth Wallace, MD, MS
Articles
October 7th 2019
Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity
Shirley Cohen-Mekelburg, MD, MS Russell Rosenblatt, MD, MS Beth Wallace, MD, MS Nicole Shen, MD, MS Brett Fortune, MD, MSc Akbar K. Waljee, MD, MSc Sameer Saini, MD, MS Ellen Scherl, MD Robert Burakoff, MD Mark Unruh, PhD
Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: January 6th 2025 | Updated: January 22nd 2025
SPOTLIGHT: Shorter Duration of Venetoclax Is Possible for Some Patients With Newly Diagnosed AML
